Financhill
Back

Morgan Stanley Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy
58

MS
Morgan Stanley

Last Price:
97.03
Seasonality Move:
2.64%
Sell
41

RARE
Ultragenyx Pharmaceutical

Last Price:
39.79
Seasonality Move:
3.65%
Buy
58
Morgan Stanley (MS) is a Buy

Is Morgan Stanley a Buy, Sell or Hold?

  • The current Morgan Stanley [MS] share price is $97.04. The Score for MS is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • MS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
41
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.80. The Score for RARE is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MS Stock Price Chart

What is Morgan Stanley's stock price today?

  • The Morgan Stanley share price today is $97.04
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MS is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.80
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

MS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 52.79 Buy
Chaikin Money Flow: 4254862 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (96.18 - 99.78) Sell
Bollinger Bands (100): (86.83 - 96.47) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.3 Sell
Relative Strength Index (14 RSI): 44 Sell
Chaikin Money Flow: 896649 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.57 - 42.35) Sell
Bollinger Bands (100): (41.42 - 48.86) Sell

MS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 96.15 Buy
20-day SMA: 97.57 Sell
50-day SMA: 95.14 Buy
200-day SMA: 87.09 Buy
8-day EMA: 96.28 Buy
20-day EMA: 96.7 Buy
50-day EMA: 95.32 Buy
200-day EMA: 89.93 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.65 Sell
20-day SMA: 40.82 Sell
50-day SMA: 42.69 Sell
200-day SMA: 42.45 Sell
8-day EMA: 41.15 Sell
20-day EMA: 41.29 Sell
50-day EMA: 42.49 Sell
200-day EMA: 43.61 Sell

Morgan Stanley Earnings Growth & MS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.28 per share, an increase next quarter of $0.30 per share, an increase this year of $1.23 per share, and an increase next year of $0.79 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.47 per share, an increase next quarter of $0.03 per share, an increase this year of $0.84 per share, and an increase next year of $1.07 per share.

Morgan Stanley Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):